SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) June 13, 2003
-------------
BECTON, DICKINSON AND COMPANY
-------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
New Jersey 001-4802 22-0760120
-------------------------------------------------------------------------------
(State or other juris- (Commission (IRS Employer Iden-
diction of incorporation) File Number) tification Number)
1 Becton Drive, Franklin Lakes, New Jersey 07417-1880
-------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (201) 847-6800
--------------
N/A
-------------------------------------------------------------------------------
(Former name or former addresses if changed since last report.)
Item 9. REGULATION FD DISCLOSURE.
The following statement is being furnished by the Company under the
provisions of Regulation FD:
On June 5, 2003, William A. Kozy, President -- BD Clinical Laboratory
Solutions and Company Operations of BD, exercised options to purchase
4,988 shares of BD. Payment of the exercise price for these options
was made by the delivery of 2,494 BD shares. Following these
transactions, Mr. Kozy's ownership interest in BD shares increased
from an aggregate of 37,657 shares to an aggregate of 40,147 shares,
including 35,438 shares owned directly and 4,709 shares held in BD's
Savings Incentive Plan.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
BECTON, DICKINSON AND COMPANY
(Registrant)
By: /s/ Gary DeFazio
----------------------------
Gary DeFazio
Assistant Secretary
Date: June 13, 2003
- 2 -